Bayer in deal to search U.K. NHS data for heart drug clues

Sensyne Health Partners with Bayer to Accelerate New Treatments for Cardiovascular Disease

Bayer, Sensyne to use AI platform to accelerate CV development

Clinical AI firm Sensyne partnering with Bayer to improve cardiovascular trials

Sensyne Health, Bayer collaborate on new AI-powered treatments for heart disease

How we can place a value on healthcare data

AI firm Sensyne Health signs £5m agreement with Bayer

Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline

Sensyne Health to collaborate with Bayer in first major deal

Sensyne Health and Bayer sign collaboration agreement to accelerate cardiovascular drug development

Sensyne Health Shares Jump As Secures Development Deal With Bayer

Sensyne Health partners with Bayer to develop treatment for heart disease using AI

Bayer taps Sensyne Health AI and real world data for cardiovascular research

Bayer CV Pact Gives AI-Focused Sensyne Health Its First Big Deal Since 2018 IPO

Sensyne Health signs collaboration agreement with Bayer

Bloomberg: Bayer Makes AI Deal to Search for Heart Drug Clues in U.K. Health Data